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A salient feature of metastasis is the ability of different tu-
mor types to colonize the same or different organ sites. Many
genetic and epigenetic events have been identified that con-
tributing to the metastatic cascades, including migration, lo-
cal invasion, intravasation, survival in the circulation, ex-
travasation and colonization, and some key molecules might
have dual functions promoting metastasis by providing both
local advantage frommalignant progression in the primary tu-
mor and a distal advantage from infiltration of distant organs.
Nevertheless, the metastatic process remains poorly under-
stood and the insight into the molecular events that initiate
and/or sustain this process remains incomplete.
The Golgi apparatus-complex is a highly dynamic or-
ganelle which is considered the “heart” of intracellular
transportation. It has been demonstrated to play an active
role in cell migration through posttranslational modification;
and prominent changes in Golgi apparatus, with disruption
at biochemical composition, structure and function levels,
have been observed in human carcinogenesis and metastasis
(Wlodkowic et al., 2009). The important cancer-specific
hallmarks of Golgi include the aberrant glycosylation and ab-
normal expression of Ras GTPases, as well as dysregulation
of cell migration (Wlodkowic et al., 2009). While frag-
mentation of the Golgi was confirmed in cancer by electron
microscopy almost fifty years ago, it is only in recent years
that we have begun to understand the significance of Golgi
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apparatus in cancer biology, especially in cancer metastasis
and progression.
Golgi-related golgi membrane protein 1 (GOLM1, also
named GOLPH2 or GP73) is a type II Golgi membrane
protein with a short N-terminal sequence in the cyto-
plasm, and its expression is induced by viral infection
(Kladney et al., 2000). It has been characterized as a diagnos-
tic marker for a number of cancers including hepatocellular
carcinoma (HCC) (Marrero et al., 2005), however, little is
known about the possible roles of GOLM1 protein in cancer
metastasis. In our recent study, based on comparing the gene
expression profiles of HCCs with and without extra-hepatic
metastasis, we identified GOLM1 as one of the leading genes
favoring HCC metastasis (Ye et al., 2016). The patients with
high GOLM1 levels in HCC had a higher possibility of early
tumor recurrence and reduced overall survival. Furthermore,
GOLM1 depletion reduced in vitro proliferation, migration,
and invasion of HCC cell lines with high levels of GOLM1,
and reduced tumor growth and lung metastases in tumor
xenografts in vivo. These indicate that GOLM1 promotes
HCC growth and metastasis.
To understand how GOLM1 to regulate cancer metastasis,
we further performed both biochemical and cell biological as-
says, and revealed that GOLM1 could physically interact with
the epidermal growth factor receptor (EGFR), a member of
receptor tyrosine kinases (RTKs) which integrates input from
multiple signaling pathways to control cell growth, prolifera-
tion, and survival. The physical interaction between GOLM1
and EGFR was required for the GOLM1-mediated enhance-
ment of the downstream AKT/S6K activation and cell migra-
tion (Ye et al., 2016). Although the precise mechanistic basis
for the activity of GOLM1 on RTKs signaling remains to be
fully elucidated, GOLM1 represents a first-in-class Golgi on-
coprotein associated with RTKs activation and cancer metas-
tasis.
Emerging evidences support the concept that the malignant
behaviors of cancer, cellular proliferation, differentiation,
invasion and metastasis, are sustained by the deregulated ac-
tivation of complex network of intracellular and extracellular
signal transduction cascades. The growth-factor-responsive
receptor tyrosine kinases have a critical role in the etiology
and/or progression of human cancers through activating
downstream signaling pathway. In addition to the multiple
mechanisms leading to the oncogenic activation of RTKs,
such as transcriptional overexpression, chromosomal translo-
cation, point mutation, and creation of an autocrine stim-
ulation loop, ligand-induced RTKs endocytosis/recycling
has recently been demonstrated to bind and phosphorylate
the downstream signaling proteins in pre-degradative intra-
cellular compartments and to activate signaling pathways.
Upon ligand binding, RTKs become catalytically active and
tyrosine phosphorylated enabling the recruitment of signal-
ing proteins to initiate downstream signaling cascades. This
process is balanced by the simultaneous recruitment of endo-
cytic proteins, which enhance RTKs internalization, allowing
for their removal from the cell surface and subsequent signal
termination (Sorkin and von Zastrow, 2009). Following the
ligand activation, RTKs, including EGFR, are internalized
through clathrin-dependent or -independent mechanisms,
eventually converging to deliver cargo to early endosomes
(Sorkin and von Zastrow, 2009) and finally towards one of
the two fates, being routed to late endosomes/lysosomes for
degradation, or being recycled back to the plasma membrane.
The ensuing sorting pathways destine cargo proteins for lyso-
some-mediated degradation or recycling back to the plasma
membrane for reactivation, thereby serving as an important
means for regulating homeostasis in receptor signaling.
Given their importance in maintaining a balance in growth
factor signaling, it is reasonable to expect that deregulated
receptor trafficking might provide a mechanism to promote
oncogenesis through delaying receptor internalization, fa-
voring recycling over degradation. In the first case, as refer
to ‘internalization phase’, internalized RTKs can continue to
signal from endosomal compartments and it is now recog-
nized that the ability of endosomes to serve as an intracellular
signaling platform is an important component of the RTKs
signaling cascade during the cancer development. More
importantly, in the latter case, as refer to “recycling phase”,
RTKs subcellular compartmentalization and recycling have
become an important theme in controlling the magnitude and
specificity of the response, which is related to cell transfor-
mation, proliferation, and migration. During this process,
defective vasicular trafficking/recycling of RTKs enables in-
ternalized proteins to return to the plasma membrane through
a recycling compartment, which is regarded as a multifaceted
hallmark of malignant cells (Mosesson et al., 2008). One of
the earliest known examples of an endocytotic protein with
transforming activity is Huntingtin interacting protein-1,
a cofactor involved with clathrin-mediated endocytosis,
overexpression of which alters clathrin trafficking, leading
to the delayed endosome-mediated degradation of RTKs
and prolonged downstream signaling through the mito-
gen-activated protein kinase and phosphoinositide 3-kinase
pathways (Hyun and Ross, 2004). The significance of
Huntingtin interacting protein-1 upregulation is further
evidenced through its correlation with poor clinical out-
come in a variety of epithelial and lymphoid malignancies
(Hyun and Ross, 2004). Although, the identification of bona
fide oncoproteins functioning in RTKs endocytotic pathways
servers for understanding the development of cancer metas-
tasis, the mechanisms and involving molecules regulating
and coordinating RTKs recycling pathway remain poorly
understood.
In our study, GOLM1 is recruited to an activated
EGFR/RTK cargo complex upon ligand stimulation. The
formation of a GOLM1-EGFR complex is localized to a
Rab11 enriched endosomal compartment, this promotes the
access of EGFR into a recycling pathway, decreases the
entry of EGFR into the degradative pathway, and prevents
EGFR degradation. The GOLM1-dependent entry of EGFR
into the recycling pathway promotes sustained downstream
activation and re-localization of EGFR towards the leading
edge to initiate localized signaling required for cell growth
and metastasis (Figure 1).
The Golgi apparatus, especially the trans-Golgi network
(TGN) is the sorting and packaging center for trafficking
cargo to the endosomes, plasma membrane, preceding Golgi
cisternae, and endoplasmic reticulum (ER). Recycling of
RTKs to the cell surface can occur either directly from the
early endosome via a “fast route”, or indirectly through a
“slow route”, traversing the endocytic recycling compart-
ment. In the later “slow route”, the cis-Golgi receives cargo
including endocytic RTKs and then progresses to the medial
and trans-Golgi where it acquires various post-translational
modification and finally recycled back to the cell surface or
to lysosomes for degradation.
Although the RTKs transportation in different subcellular
compartments is mainly modulated by Golgi apparatus, and
is able to sort RTKs into recycling or degradation after lig-
and binding, little is known about the mechanisms of the
Golgi-related molecules controlling the intracellular trans-
portation/recycling of RTKs as well as their possible roles in
cancer metastasis.
In  a  recent  study,  Christine  and  their c olleagues  have
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Figure 1   Illustration depicting possible routes for GOLM1-mediated RTK recycling. Following ligand binding, cell surface receptors such as RTKs are
destined for internalization for receptor recycling or lysosome-mediated destruction. GOLM1 localization to the Golgi apparatus and, enhances RTKs recycling
in assistance with Rab GTP to strengthen the downstream signaling cascades.
reported Golgi-localized gamma-ear containing Arf-binding
protein 3 (GGA3) is recruited to an activated Met/RTK cargo
complex present within the early tubular endosomal net-
work. The formation of a GGA3-Met/RTK complex would
promote the access of Met/RTK into a recycling pathway
while decrease the entry of Met/RTK into the degradative
pathway. GGA3-dependent entry of Met/RTK into the
recycling pathway, promotes sustained ERK1/2 activation
and re-localization of Met/RTK towards the leading edge
to initiate localized signaling required for cell migration
(Parachoniak et al., 2011). Moreover, GOLPH3, another
family member of Golgi phosphoprotein, was demonstrated
to localize at the peripheral structures including the en-
dosomal compartments and the plasma membrane, which
suggests that GOLPH3 may traffic to these structures, hence
facilitating cargo sorting from the Golgi (Scott et al., 2009).
GOLM1, much more like GOLPH3, localizes at the cis-
Golgi via a lumenal targeting signal within its coiled-coil
stem domain, and its retrieval from post-Golgi structures oc-
curs via the microtubule- and PI3 kinase independent, late
endosome bypass pathway, which sorts a subset of proteins,
at the early endosome away from those enroute to the late en-
dosome/lysosome for direct recycling to the Golgi apparatus
(Puri et al., 2002). We have also noticed that GOLM1, simi-
lar to the structurally related protein GPP130 cycles between
the Golgi and the cell surface, may be involved in RTKs in-
tracellular trafficking and recycling following ligand bind-
ing. We speculate that GOLM1 functions as a specific cargo
adaptor to assist RTKs anchoring on the TGN and recycling
back to plasma membrane, rather than degradation pathway,
which allows for the prolonged activation of AKT/S6K from
endosomes. The biological function of endosomal GOLM1
cycling in cancer development remains to be further inves-
tigated. Future work will be required to further determine
the mechanism of GOLM1-mediated RTKs intracellular traf-
ficking and recycling, and more importantly, Golgi regulated
RTKs recycling on difference cancer cells.
In summary, these findings of our study indicate that
GOLM1 may promote HCC by regulation of EGFR/RTK
recycling, and suggest that therapeutic targeting of GOLM1
may be a potential strategy for combating HCC metastasis.
The components of these pathways might represent novel
therapeutic targets against cancer; therefore, additional in-
sight into the biological activity of GOLM1 may ultimately
serve as an entry point to translate the modifiers of these
pathways into clinical endpoints.
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